Is your company seeking a next round of financing or hoping to make the valuable connection needed to take your product into the next phase? Nominations are now being accepted for this year’s Buzz of BIO at the BIO Investor Forum! Take advantage of this unparalleled opportunity to spotlight your company in front of hundreds of potential partners.
Ten biotechs will be nominated in each of the three categories, “Early Stage Entrepreneurs”, “Late Stage Leaders” and “Diagnostics and Beyond”.
- To qualify for the Early Stage Entrepreneur Grand Prize, companies must be actively developing a therapeutic product intended for FDA review that addresses human health issues, and have raised less than $25 million USD as of July 1, 2017; have been founded after 2012; and have most recently completed either a Seed or Series A financing round. Companies that have previously presented at the BIO Investor Forum are not eligible for the Early Stage Entrepreneur category, but are welcome to apply under the Late Stage Leader category (if the company meets the minimum dollar requirements of the Late Stage Leader category).
- To qualify for the Late Stage Leader Grand Prize, companies must be actively developing a therapeutic product intended for FDA review that addresses human health issues, and have raised more than $25 million USD as of July 1, 2017 and/or have been founded before 2012.
- To qualify for the Diagnostics and Beyond category, companies must be primarily focused in medical diagnostics, drug delivery, drug development tools, or digital health technologies.
Buzz of BIO winners receive complimentary conference registration, a Company Presentation and will be showcased in a spotlight in BioCentury Extra.
Don’t miss this opportunity! Nominations will only be accepted until August 22, 5pm ET.